Stay updated on Empagliflozin US Comparative Effectiveness Clinical Trial
Sign up to get notified when there's something new on the Empagliflozin US Comparative Effectiveness Clinical Trial page.

Latest updates to the Empagliflozin US Comparative Effectiveness Clinical Trial page
- Check2 days agoChange DetectedThe study page continues to show a 403 Forbidden error instead of a study record, with the footer showing revision v3.7.1.SummaryDifference0.2%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe study record page now displays a 403 Forbidden error page, replacing the expected study details and navigation. This indicates the record is currently inaccessible to users.SummaryDifference18%

- Check44 days agoChange DetectedFooter revision updated from v3.6.5 to v3.6.6, reflecting a minor page update. The study details and information shown remain unchanged.SummaryDifference0.1%

- Check66 days agoChange DetectedThe site's revision indicator was updated from v3.6.4 to v3.6.5, representing a new build of the interface. No study content or data were modified.SummaryDifference0.1%

- Check80 days agoChange DetectedThe study record was updated to revision v3.6.4 on 2026-07-21/22. It changes the status from Active, not recruiting and Estimated to Completed with Actual enrollment data.SummaryDifference0.5%

- Check94 days agoChange DetectedJuly 2026 administrative timestamps were added to the study record, indicating a recent update, and older June timestamps were removed.SummaryDifference0.3%

Stay in the know with updates to Empagliflozin US Comparative Effectiveness Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Empagliflozin US Comparative Effectiveness Clinical Trial page.